Skip to main content
. Author manuscript; available in PMC: 2016 Aug 8.
Published in final edited form as: Cancer. 2011 Jun 29;118(2):418–427. doi: 10.1002/cncr.26292

Table 6.

Lack of Use of Cenersen Inhibitors is Associated with Obtaining a Response in Patients with an Evaluable BM and Meeting Entry Criteria

Administration of Prohibited
Substances
(number of patients)
Responses
CR + CRp NR P-value
Yes (14) 0 14 0.0174
No (28) 10 18

CR indicates complete response

CRp indicates complete response with incomplete platelet recovery

NR indicates no response